Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Terminated
Washington University School of Medicine
Phase 4
2013-12-01
This double-blinded, placebo-controlled, randomized trial will compare the effects of the use
of a combined oral contraceptive pill to a placebo pill for women who are experiencing
irregular and/or heavy bleeding associated with the use of an etonogestrel (ETG) implant.
The hypothesis of the study is:
- Use of combined oral contraceptive will significantly improve bleeding patterns for
users of ETG implant
- Continuation rate of ETG implant users will be increased by use of combined oral
contraceptive in women desiring ETG implant removal because of the undesirable bleeding
- Adverse events will be uncommon and acceptable to women who use a combined oral
contraceptive with the ETG implant
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Terminated
University of California, Davis
Phase 4
2013-12-01
This double-blinded, placebo-controlled, randomized trial will compare the effects of the use
of a combined oral contraceptive pill to a placebo pill for women who are experiencing
irregular and/or heavy bleeding associated with the use of an etonogestrel (ETG) implant.
The hypothesis of the study is:
- Use of combined oral contraceptive will significantly improve bleeding patterns for
users of ETG implant
- Continuation rate of ETG implant users will be increased by use of combined oral
contraceptive in women desiring ETG implant removal because of the undesirable bleeding
- Adverse events will be uncommon and acceptable to women who use a combined oral
contraceptive with the ETG implant
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
